DE69432838D1 - Gensonden und Verfahren zum Nachweis vom menschlichen Immunschwäche-Virus Typ 1 - Google Patents

Gensonden und Verfahren zum Nachweis vom menschlichen Immunschwäche-Virus Typ 1

Info

Publication number
DE69432838D1
DE69432838D1 DE69432838T DE69432838T DE69432838D1 DE 69432838 D1 DE69432838 D1 DE 69432838D1 DE 69432838 T DE69432838 T DE 69432838T DE 69432838 T DE69432838 T DE 69432838T DE 69432838 D1 DE69432838 D1 DE 69432838D1
Authority
DE
Germany
Prior art keywords
hiv
nucleic acid
detection
immunodeficiency virus
human immunodeficiency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69432838T
Other languages
English (en)
Other versions
DE69432838T2 (de
Inventor
Sherrol H Mcdonough
Thomas B Ryder
Yeasing Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gen Probe Inc
Original Assignee
Gen Probe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Probe Inc filed Critical Gen Probe Inc
Application granted granted Critical
Publication of DE69432838D1 publication Critical patent/DE69432838D1/de
Publication of DE69432838T2 publication Critical patent/DE69432838T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69432838T 1993-03-26 1994-03-28 Gensonden und Verfahren zum Nachweis vom menschlichen Immunschwäche-Virus Typ 1 Expired - Lifetime DE69432838T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4074593A 1993-03-26 1993-03-26
US40745 1993-03-26

Publications (2)

Publication Number Publication Date
DE69432838D1 true DE69432838D1 (de) 2003-07-31
DE69432838T2 DE69432838T2 (de) 2004-05-13

Family

ID=21912702

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69432838T Expired - Lifetime DE69432838T2 (de) 1993-03-26 1994-03-28 Gensonden und Verfahren zum Nachweis vom menschlichen Immunschwäche-Virus Typ 1

Country Status (9)

Country Link
US (2) US6252059B1 (de)
EP (2) EP0617132B1 (de)
JP (1) JP4108118B2 (de)
KR (1) KR100325554B1 (de)
AT (1) ATE243762T1 (de)
AU (1) AU686616B2 (de)
CA (1) CA2159103C (de)
DE (1) DE69432838T2 (de)
WO (1) WO1994023069A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589734B1 (en) * 1989-07-11 2003-07-08 Gen-Probe Incorporated Detection of HIV
US5733781A (en) * 1994-07-19 1998-03-31 Gen-Probe Incorporated Oligonucleotides and methods for inhibiting propagation of human immunodeficiency virus
US5599662A (en) * 1995-02-17 1997-02-04 Hoffmann-La Roche Inc. Oliconucleotide primers and probes for the detection of HIV-1
US5731148A (en) * 1995-06-07 1998-03-24 Gen-Probe Incorporated Adduct protection assay
EP0796347A2 (de) * 1995-09-21 1997-09-24 Becton, Dickinson and Company Nachweis von nukleinsäure in zelle unter verwendung von thermophilen strangverdrängungsamplifikation
DE19644248A1 (de) * 1996-10-24 1998-04-30 Boehringer Mannheim Gmbh Primer und Probes zum Nachweis von HIV
US6025133A (en) * 1996-12-30 2000-02-15 Gen-Probe Incorporated Promoter-sequestered oligonucleoside and method of use
CA2222769C (en) * 1997-01-17 2001-06-12 F. Hoffmann-La Roche Ag Primers for the detection of hiv-1
US5962665A (en) * 1997-06-16 1999-10-05 Abbott Laboratories Nucleic acid primers and probes for detecting HIV-1 and HIV-2
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2
JP3689333B2 (ja) * 1997-08-08 2005-08-31 アクゾ・ノベル・エヌ・ベー Ｈｉｖ−１の全てのサブタイプを増幅及び検出するためにプライマー及びプローブとして使用できる核酸配列
US6846905B2 (en) 1997-08-15 2005-01-25 Abbott Laboratories Antigen constructs useful in the detection and differentiation of antibodies to HIV
US7244570B2 (en) 1998-08-04 2007-07-17 Luminex Molecular Diagnostics, Inc. Methods and compositions for modulating “marginally indiscriminant” hybridizations
DE19850186A1 (de) * 1998-10-30 2000-05-25 Roche Diagnostics Gmbh Neue Primer und Sonden zum Nachweis von HIV
WO2000039304A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US6602705B1 (en) 1998-12-31 2003-08-05 Chiron Corporation Expression of HIV polypeptides and production of virus-like particles
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
AU2596600A (en) 1998-12-31 2000-07-31 Chiron Corporation Modified hiv env polypeptides
WO2000046403A2 (en) * 1999-02-03 2000-08-10 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OFHEALT H AND HUMAN SERVICES Methods and reagents for molecular detection of hiv-1 groups m, n and o
US6821770B1 (en) * 1999-05-03 2004-11-23 Gen-Probe Incorporated Polynucleotide matrix-based method of identifying microorganisms
ATE456677T1 (de) * 1999-07-09 2010-02-15 Gen Probe Inc Hiv-1 detektion mittels nukleinsäureamplifizierung
EP1233976A4 (de) * 1999-11-17 2003-06-11 Jiuping Ji Simultaner nachweis von hbv, hcv und hiv in plasmaproben mit hilfe eines multiplexen fixierungstests
CA2406830C (en) * 2000-04-20 2012-10-02 Virco Bvba Method for mutation detection in hiv using pol sequencing
US6800463B1 (en) * 2000-04-20 2004-10-05 Virco Bvba Method for mutation detection in HIV-1 using pol sequencing
US6582920B2 (en) 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
AU7104200A (en) * 2000-09-01 2002-03-22 Gen Probe Inc Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations
US6770752B2 (en) 2001-01-09 2004-08-03 Becton, Dickinson And Company Sequences for detection of HIV-1
US6753145B2 (en) * 2001-07-05 2004-06-22 Agilent Technologies, Inc. Buffer composition and method for hybridization of microarrays on adsorbed polymer siliceous surfaces
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
AU2002316578A1 (en) 2001-08-31 2003-03-18 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US7132236B2 (en) * 2001-10-25 2006-11-07 Agilent Technologies, Inc. Composition and method for optimized hybridization using modified solutions
WO2005061735A2 (en) * 2003-12-04 2005-07-07 The Government Of The United States Of America As Represented By The Department Of Health Human Servicees Strand-specific amplification
CA2547750C (en) 2003-12-19 2014-04-08 Gen-Probe Incorporated Compositions, methods and kits for detecting the nucleic acids of hiv-1 and hiv-2
DE602005027809D1 (de) * 2004-01-07 2011-06-16 Hitachi Chemical Co Ltd Primer und sonden zum nachweis von hiv
FR2869045A1 (fr) * 2004-04-16 2005-10-21 Bioalliance Pharma Sa Methode d'etude de la variabilite genetique et fonctionnelle du vih et kit pour sa mise en oeuvre
EP1602736A1 (de) * 2004-06-04 2005-12-07 Bio-Rad Pasteur Detektion von HIV Typen und Subtypen
CA2579676A1 (en) 2004-09-08 2007-02-15 Hana Golding Compositions and methods for the detection of hiv-1/hiv-2 infection
US7964413B2 (en) 2005-03-10 2011-06-21 Gen-Probe Incorporated Method for continuous mode processing of multiple reaction receptacles in a real-time amplification assay
EP1930730B1 (de) 2005-03-10 2019-08-14 Gen-Probe Incorporated Systeme und Verfahren zur Durchführung von Tests zum Nachweis oder zur Quantifizierung von Analyten
WO2007055260A1 (ja) * 2005-11-11 2007-05-18 Japan Health Sciences Foundation 人免疫不全ウイルス－１遺伝子検出又は定量用材料，検出又は定量方法，治療用遺伝子断片，及び治療方法
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
JP2010521156A (ja) * 2007-03-16 2010-06-24 ４５４ ライフ サイエンシーズ コーポレイション Ｈｉｖ薬物耐性バリアントの検出のためのシステムおよび方法
ITRM20070254A1 (it) * 2007-05-03 2008-11-04 Univ Palermo Metodo per la genotipizzazione di hiv-1 e relativi kit diagnostici per la rilevazione di farmaco-resistenze.
WO2009017743A2 (en) * 2007-07-30 2009-02-05 Argos Therapeutics, Inc. Improved primers and probes for the amplification and detection of hiv gag, rev and nef polynucleotides
GB0814570D0 (en) 2008-08-08 2008-09-17 Diagnostics For The Real World Isolation of nucleic acid
SG178016A1 (en) * 2009-07-07 2012-04-27 Agency Science Tech & Res Human immunodeficiency virus type 1 (hiv-1) detection method and kit therefor
WO2012123591A1 (en) * 2011-03-17 2012-09-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for targeting nucleic acids to the nucleus
AU2013308647B2 (en) 2012-08-30 2018-10-18 Gen-Probe Incorporated Multiphase nucleic acid amplification
EP3068907A4 (de) * 2013-11-14 2017-06-14 The General Hospital Corporation Gegen hiv-reservoirs gerichtete suizidkontrastmittel für theranostische tilgung
DE112016003948T5 (de) 2015-08-31 2018-05-09 City Of Sapporo Molekulare verfahren zum beurteilen einer urothelialen erkrankung

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3486467T3 (de) 1983-01-10 2004-10-14 Gen-Probe Inc., San Diego Verfahren zum Nachweis, Identifizieren und Quantifizieren von Organismen und Viren
US9328391B1 (en) 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
CA1341423C (en) 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
US4754065A (en) * 1984-12-18 1988-06-28 Cetus Corporation Precursor to nucleic acid probe
US5008182A (en) * 1986-01-10 1991-04-16 Cetus Corporation Detection of AIDS associated virus by polymerase chain reaction
AU606043B2 (en) 1985-03-28 1991-01-31 F. Hoffmann-La Roche Ag Detection of viruses by amplification and hybridization
ATE88762T1 (de) 1986-08-11 1993-05-15 Siska Diagnostics Inc Methoden und zusammensetzungen fuer tests mit nukleinsaeuresonden.
US5079351A (en) 1986-11-26 1992-01-07 Cetus Corporation Oligonucleotides and kits for detection of htlvi and htlvii viruses by hybridization
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
US5283174A (en) 1987-09-21 1994-02-01 Gen-Probe, Incorporated Homogenous protection assay
AU2714988A (en) 1987-10-23 1989-06-01 Siska Diagnostics, Inc. Lanthanide chelate-tagged nucleic acid probes
US5030557A (en) 1987-11-24 1991-07-09 Ml Technology Venture Means and method for enhancing nucleic acid hybridization
CA2002076A1 (en) 1988-11-21 1990-05-21 Brent A. Burdick Diagnostic kit and method using a solid phase capture means for detecting nucleic acids
AU4829690A (en) 1988-12-16 1990-07-10 Siska Diagnostics, Inc. Self-sustained, sequence replication system
CA2026573A1 (en) 1989-02-03 1990-08-04 John B. Findlay Nucleic acid test article and its use to detect a predetermined nucleic acid
ATE466111T1 (de) * 1989-06-02 2010-05-15 Pasteur Institut Nukleotidsequenzen des genoms von retroviren des typs hiv-1, hiv-2 und siv und deren anwendungen, insbesondere zur amplifikation von genomen dieser retroviren und für die in-vitro-diagnostik von durch diese viren ausgelösten infektionen
US5856088A (en) 1989-07-11 1999-01-05 Gen-Probe Incorporated Detection of human immunodeficiency virus type 1
ES2091225T3 (es) * 1989-07-11 1996-11-01 Gen Probe Inc Metodos para la amplificacion de las secuencias de acidos nucleicos.
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
WO1991008308A1 (en) * 1989-11-30 1991-06-13 Pharmacia Genetic Engineering, Inc. A new method for detecting a specific nucleic acid sequence in a sample of cells
CA2032203C (en) 1989-12-29 2009-05-19 Christine L. Brakel Amplification capture assay
PT96458B (pt) * 1990-01-10 1998-06-30 Chiron Corp Utilizacao de transcritos de rna polimerase dependentes de dna como moleculas registadoras para amplificacao de sinal em ensaios de hibridazacao de acidos nucleicos
US5427930A (en) * 1990-01-26 1995-06-27 Abbott Laboratories Amplification of target nucleic acids using gap filling ligase chain reaction
US5166195A (en) 1990-05-11 1992-11-24 Isis Pharmaceuticals, Inc. Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
FR2663949A1 (fr) * 1990-06-29 1992-01-03 Genset Sa Perfectionnements a un procede d'amplification enzymatique in vitro.
CA2087724C (en) * 1990-07-24 2003-09-16 John J. Sninsky Reduction of non-specific amplification during in vitro nucleic acid amplification using modified nucleic acid bases
JPH0491790A (ja) * 1990-08-02 1992-03-25 Shionogi & Co Ltd ２段階ｐｃｒ法
US5210015A (en) * 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
CA2083173A1 (en) * 1991-03-21 1992-09-22 Leonard J. Seaberg Element and method for nucleic acid amplification and detection using adhered probes
CA2065719A1 (en) * 1991-04-30 1992-10-31 John B. Findlay Nucleic acid amplification and detection methods using rapid polymerase chain reaction cycle
FR2677039B1 (fr) * 1991-05-31 1994-09-09 Cis Bio Int Oligonucleotides, utilisables comme reactifs pour la detection in vitro des infections a retrovirus de type hiv et procede de detection de retrovirus de type hiv.
EP1156102A1 (de) * 1991-06-14 2001-11-21 Virogenetics Corporation Rekombinanter hiv-spezifischer Impfstoff aus Poxvirus
DE69213112T2 (de) * 1991-06-20 1997-04-03 Hoffmann La Roche Verbesserte Methoden zur Nukleinsäure-Amplifizierung
GB9116042D0 (en) * 1991-07-24 1991-09-11 Royal Free Hosp School Med Diagnostic method
EP0525882B1 (de) * 1991-08-02 2004-01-14 bioMerieux B.V. Quantifikation von Nukleinsäuren
DK173091D0 (da) * 1991-10-11 1991-10-11 Schleroseforeningen The Danish Biologisk materiale
EP0726962B1 (de) * 1991-12-23 2006-06-07 Chiron Corporation Sätze von HIV Sonden für Solution Sandwich Hybridationsverfahren
JPH08500005A (ja) 1992-03-27 1996-01-09 ホワイトヘッド インスティチュート フォー バイオメディカル リサーチ 非感染性ｈｉｖ粒子およびその用途
JPH08500481A (ja) 1992-05-11 1996-01-23 リボザイム・ファーマシューティカルズ・インコーポレーテッド ウイルスの複製を阻害するための方法および薬剤
ES2048652B1 (es) * 1992-06-05 1994-10-01 Inst De Salud Carlos Iii Procedimientos de amplificacion de genoma para la deteccion e identificacion de secuencias genomicas relacionadas.
US5366885A (en) 1992-06-09 1994-11-22 Barranco Iii Sam C Method and kit for testing tumors for drug sensitivity
WO1994003635A1 (en) * 1992-08-04 1994-02-17 Institute Of Molecular Biology & Biotechnology Rapid amplification and detection of nucleic acids
EP0890642A3 (de) * 1992-10-06 2000-09-13 Dade Behring Marburg GmbH Retrovirus aus der HIV-Gruppe und dessen Verwendung

Also Published As

Publication number Publication date
WO1994023069A1 (en) 1994-10-13
AU686616B2 (en) 1998-02-12
KR100325554B1 (ko) 2002-11-02
KR960701219A (ko) 1996-02-24
EP0617132A2 (de) 1994-09-28
CA2159103A1 (en) 1994-10-13
US6252059B1 (en) 2001-06-26
DE69432838T2 (de) 2004-05-13
EP0617132A3 (en) 1995-11-29
CA2159103C (en) 2002-03-12
JP4108118B2 (ja) 2008-06-25
ATE243762T1 (de) 2003-07-15
EP1344837A1 (de) 2003-09-17
EP0617132B1 (de) 2003-06-25
AU6551594A (en) 1994-10-24
JPH08508404A (ja) 1996-09-10
US6649749B2 (en) 2003-11-18
US20020062016A1 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
DE69432838D1 (de) Gensonden und Verfahren zum Nachweis vom menschlichen Immunschwäche-Virus Typ 1
ATE237698T1 (de) Primers und sonden zum nachweis von hiv
US5389512A (en) Method for determining the relative amount of a viral nucleic acid segment in a sample by the polymerase chain reaction
ATE185379T1 (de) Nukleotid-sequenzen des genoms von retroviren vom typ hiv-1, hiv-2 und siv, ihre verwendungen zur amplifikation dieser genome und in-vitro-diagnose dieser viralen infektionen
Delwart et al. Genetic subtyping of human immunodeficiency virus using a heteroduplex mobility assay.
US5589333A (en) In situ polymerase chain reaction
KR20010014470A (ko) Ｈｉｖ-1 및 ｈｉｖ-2를 효율적으로 검출하기 위한올리고뉴클레오타이드 역전사 프라이머 및 이의 사용 방법
RU2186112C2 (ru) Олигонуклеотидный праймер, пара праймеров, набор праймеров (варианты), способ их изготовления для амплификации нуклеиновой кислоты вич-1
Nycz et al. Quantitative reverse transcription strand displacement amplification: quantitation of nucleic acids using an isothermal amplification technique
Karageorgos et al. Stepwise analysis of reverse transcription in a cell-to-cell human immunodeficiency virus infection model: kinetics and implications
Delwart et al. Heteroduplex mobility assays for phylogenetic analysis
Jurriaans et al. Analysis of human immunodeficiency virus type 1 LTR-LTR junctions in peripheral blood mononuclear cells of infected individuals
Kumar et al. A Method for the Rapid Screening of Human Blod Samples for the Presence of HIV-1 Sequences: The Probe-Shift Assay
Bell et al. Specificity of polymerase chain amplification reactions for human immunodeficiency virus type 1 DNA sequences
Kostrikis et al. Genotyping HIV-1 and HCV strains by a combinatorial DNA melting assay (COMA)
JP4130487B2 (ja) 核酸の同時増幅方法
Teglbjærg et al. Sensitive non-radioactive detection of HIV-1: use of nested primers for the amplification of HIV DNA
RU93013954A (ru) Способ обнаружения вируса иммунодефицита

Legal Events

Date Code Title Description
8364 No opposition during term of opposition